How long does Cell Stem Cell take to review?

Cell Stem Cell typically takes 30-45 days. The full review process involves 6 main stages: pre-submission inquiry (optional but recommended), initial submission via editorial manager, and peer review.

All Journal Guides

Journal Guide

Cell Stem Cell Impact Factor 19.8: Publishing Guide

Q: What is the impact factor of Cell Stem Cell?

Cell Stem Cell has an impact factor of 19.8 (2024). This places it among the top-tier journals in its field with Cell Stem Cell publishes research that advances our mechanistic understanding of how stem cells maintain themselves, make fate decisions, and contribute to tissue homeostasis or disease.

Q: What is the acceptance rate of Cell Stem Cell?

Cell Stem Cell has an acceptance rate of ~10%. A common reason for rejection is over-relying on single-cell transcriptomics without functional follow-up. ScRNA-seq has become table stakes for stem cell papers, but editors see too many submissions where the single-cell data is the entire story. You've clustered cells and annotated populations - great, but what does that tell us about function? Reviewers will ask for genetic perturbation of key genes you've identified, for transplantation of sorted populations, for in vivo validation that your computationally defined cell states actually exist and matter. Build these experiments into your original study design rather than scrambling during revision.

Q: Is Cell Stem Cell peer reviewed?

Yes, Cell Stem Cell is fully peer reviewed. All submissions undergo rigorous peer review by Expect three reviewers with deep expertise in your specific area. Reviews are typically thorough and ask for substantial additional experiments. Cell Stem Cell reviewers are known for requesting in vivo validation, additional time points, and orthogonal approaches. Budget at least three to six months for revisions if you receive an invitation to revise..

Q: What does Cell Stem Cell look for in submissions?

Genetic lineage tracing with functional validation: Marker expression alone won't cut it here. Editors expect Cre-lox or other genetic lineage tracing systems that definitively establish cell origins and fates. You'll need to combine this with functional assays - transplantation, genetic ablation, or in vivo manipulation - that prove your proposed stem cells actually do what you claim. Papers that rely solely on scRNA-seq to infer lineage relationships without genetic validation rarely make it through review.

Q: What should I know before submitting to Cell Stem Cell?

Front-load your most compelling lineage tracing data. Editors make initial decisions quickly, often based on the first two figures. If you've done rigorous genetic lineage tracing, don't bury it in figure four behind descriptive characterization. Lead with the data that proves your stem cells are real and functional. Reviewers who see strong lineage tracing upfront approach the rest of the paper with more goodwill.

Cell Press's flagship stem cell journal demands rigorous lineage tracing and functional validation that goes well beyond descriptive phenotyping. If you can't prove your cells do what you claim they do in vivo, don't submit here.

19.8

Impact Factor (2024)

~10%

Acceptance Rate

30-45 days

Time to First Decision

What Cell Stem Cell Publishes

Cell Stem Cell publishes research that advances our mechanistic understanding of how stem cells maintain themselves, make fate decisions, and contribute to tissue homeostasis or disease. The journal isn't interested in papers that simply describe a new stem cell population - you need to show how it works and why it matters. Editors want studies that reveal fundamental principles applicable beyond your specific system, whether that's hematopoiesis, intestinal renewal, or neural stem cells. They're particularly drawn to work connecting stem cell biology to human disease, aging, or regenerative medicine applications, but the basic science must be rock solid first.

Molecular mechanisms controlling stem cell self-renewal versus differentiation decisions, with emphasis on transcriptional networks, epigenetic regulators, and signaling pathway crosstalk that you've functionally validated.
Lineage tracing studies that definitively map stem cell contributions to tissue development, homeostasis, and regeneration - they want genetic tools, not just marker expression.
Stem cell niche biology including how microenvironmental signals regulate stem cell behavior, and how niche dysfunction contributes to aging or disease.
Disease modeling using patient-derived iPSCs or organoids, provided you've moved beyond 'we made organoids that look sick' to actual mechanistic insight.
Regenerative medicine advances including directed differentiation protocols, but only when paired with in vivo functional data showing therapeutic relevance.

Editor Insight

“I spend most of my time at the desk rejection stage, and I'll tell you what makes me move a paper forward: I need to believe your stem cells are real within the first two figures. That means genetic lineage tracing showing self-renewal and multipotency, or clonal analysis with functional readouts. If you're showing me marker expression and in vitro sphere formation, I'm already skeptical. We get about 1,200 submissions per year, and I can only send maybe 400 to review. The papers that advance share a common feature - they don't just describe what happens, they explain the mechanism and show why it matters for human biology or disease. I'm also looking for rigor that holds up under scrutiny. When I see N equals 3 for a transplantation experiment or unblinded quantification of differentiation efficiency, I know reviewers will tear it apart. Do the statistics right the first time. And please, if your story is really about mouse hematopoiesis, don't stretch to include human data that doesn't really support your model - we can tell when human figures are afterthoughts.”

What Cell Stem Cell Editors Look For

Genetic lineage tracing with functional validation

Marker expression alone won't cut it here. Editors expect Cre-lox or other genetic lineage tracing systems that definitively establish cell origins and fates. You'll need to combine this with functional assays - transplantation, genetic ablation, or in vivo manipulation - that prove your proposed stem cells actually do what you claim. Papers that rely solely on scRNA-seq to infer lineage relationships without genetic validation rarely make it through review.

Mechanism over phenomenology

Describing that something happens isn't enough - you need to explain why and how it happens at a molecular level. If you've identified a transcription factor that controls stem cell fate, editors want epistasis experiments, chromatin profiling, and identification of direct target genes. They're looking for the kind of mechanistic depth that opens new research directions rather than simply cataloging another regulator.

Human relevance or clear translational path

Pure mouse genetics papers can still succeed here, but they need to either address a fundamental biological question or include human validation data. If you're studying intestinal stem cells in mice, show that the same pathway operates in human organoids. The journal sits at the intersection of basic and translational research, and editors want work that speaks to both audiences.

Quantitative rigor throughout

Cell Stem Cell reviewers are notoriously tough on statistics and quantification. Clone counting, flow cytometry gating strategies, image quantification methods - all need to be clearly described and appropriately powered. N values that seem fine for other journals often get flagged here as underpowered, especially for in vivo experiments. Plan for larger cohorts than you think you'll need.

Technical innovation that enables new biology

The journal publishes methods papers, but only when the technical advance enables biological discoveries that weren't previously possible. A new organoid protocol that simply grows faster won't interest editors. A new protocol that reveals previously inaccessible cell types or behaviors, validated by applying it to answer a real biological question, stands a much better chance.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past Cell Stem Cell's editorial review:

Over-relying on single-cell transcriptomics without functional follow-up

ScRNA-seq has become table stakes for stem cell papers, but editors see too many submissions where the single-cell data is the entire story. You've clustered cells and annotated populations - great, but what does that tell us about function? Reviewers will ask for genetic perturbation of key genes you've identified, for transplantation of sorted populations, for in vivo validation that your computationally defined cell states actually exist and matter. Build these experiments into your original study design rather than scrambling during revision.

Claiming stemness without serial transplantation or clonal analysis

The gold standard for proving a cell is a stem cell hasn't changed: serial transplantation showing long-term, multilineage reconstitution, or clonal analysis demonstrating self-renewal and differentiation from single cells. Papers that call cells 'stem cells' based on marker expression or in vitro sphere formation get desk-rejected regularly. If you can't do serial transplantation in your system, you need clonal lineage tracing in vivo at minimum.

Submitting organoid papers without in vivo validation

Organoids are powerful tools, but they're also reductionist models that don't capture the full complexity of in vivo stem cell behavior. Editors increasingly expect that key findings from organoid studies be validated in animal models or human tissue samples. A paper showing that a drug affects organoid growth means little if you can't show it affects actual tumor stem cells in vivo. Plan for mouse experiments from the start.

Presenting incremental advances in known pathways

We already know Wnt is important for intestinal stem cells and Notch matters in hematopoiesis. Adding another component to a well-established pathway, even with beautiful mechanistic data, won't excite editors unless it fundamentally changes how we think about that pathway or reveals unexpected connections. Cell Stem Cell wants papers that shift paradigms, not papers that fill in boxes on established models.

Underestimating the rigor of differentiation validation

Claiming you've made a specific cell type from pluripotent stem cells requires more than marker expression and morphology. Reviewers expect functional assays appropriate to your target cell type - electrophysiology for neurons, glucose-stimulated insulin secretion for beta cells, engraftment and maturation for hematopoietic cells. They'll also want comparison to primary cells using transcriptomics or proteomics. Papers with weak differentiation validation get sent back immediately.

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against Cell Stem Cell's criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from Cell Stem Cell Authors

Front-load your most compelling lineage tracing data

Editors make initial decisions quickly, often based on the first two figures. If you've done rigorous genetic lineage tracing, don't bury it in figure four behind descriptive characterization. Lead with the data that proves your stem cells are real and functional. Reviewers who see strong lineage tracing upfront approach the rest of the paper with more goodwill.

Include human data even for primarily mouse studies

Even a single figure showing your mouse findings hold in human cells can dramatically improve your chances. This doesn't need to be as mechanistically deep as your mouse work - human organoids, analysis of existing human scRNA-seq datasets, or immunohistochemistry on human tissue sections can all serve this purpose. Editors specifically look for papers that bridge species.

Address the niche question explicitly

Stem cell papers that ignore the microenvironment feel incomplete to Cell Stem Cell editors. Even if your paper focuses on intrinsic regulators, include some data or discussion about how the niche might influence your findings. This shows you understand the field's current priorities and aren't studying stem cells in a vacuum.

Pre-submission inquiries actually work here

Unlike some journals where pre-submission inquiries get generic encouragement, Cell Stem Cell editors provide genuine feedback on whether your story fits. If you're uncertain about scope, send a one-page summary before investing time in formatting. A frank 'this isn't right for us' saves everyone months of work.

Prepare for the 'so what' question at every level

Reviewers here don't just ask whether your experiments work - they ask why anyone should care. Build your paper around a clear narrative of biological significance. Every experiment should answer not just 'what happens' but 'why does this matter for understanding stem cell biology or treating disease.' Papers that feel like collections of experiments rather than coherent stories struggle here.

The Cell Stem Cell Submission Process

Pre-submission inquiry (optional but recommended)

1-2 weeks for response

Send a half-page to one-page abstract outlining your main findings and their significance. Include key figures if they're ready. Editors typically respond within a week with either encouragement to submit, suggestions for additional experiments, or a frank assessment that the work isn't right for the journal. This step can save months of wasted effort.

Initial submission via Editorial Manager

Allow 2-3 hours for submission

Submit your manuscript with cover letter, figures, and supplementary materials through Cell Press's submission portal. The cover letter matters here - explicitly address why your work fits Cell Stem Cell rather than Cell Reports or Stem Cell Reports. Explain what's conceptually new, not just technically impressive. Suggest reviewers who can evaluate your lineage tracing and functional assays.

Editorial assessment

1-2 weeks

A handling editor evaluates your submission for scope, novelty, and likely impact. About 50-60% of papers are desk-rejected at this stage, usually within two weeks. If your paper advances, it means an editor sees real potential - take heart from this even when reviews are tough. Desk rejection doesn't mean bad science, just that it's not what Cell Stem Cell publishes.

Peer review

4-6 weeks for reviews

Expect three reviewers with deep expertise in your specific area. Reviews are typically thorough and ask for substantial additional experiments. Cell Stem Cell reviewers are known for requesting in vivo validation, additional time points, and orthogonal approaches. Budget at least three to six months for revisions if you receive an invitation to revise.

Revision and resubmission

3-6 months typically needed

Revision invitations aren't guaranteed acceptances - they're genuine invitations to strengthen your paper. Respond to every point thoroughly, and if you disagree with a reviewer, explain why with data rather than argument. New experiments are almost always required. Partial revisions or responses that seem to dodge requests often lead to rejection at the re-review stage.

Final decision and production

4-6 weeks to publication

Accepted papers move quickly through production. You'll work with Cell Press copyeditors who are rigorous about nomenclature and data presentation standards. Proofs require careful attention - this is your last chance to catch errors. From acceptance to online publication typically takes about four weeks.

Cell Stem Cell by the Numbers

2024 Impact Factor(Down from peak of 24.6 in 2021 but still top-tier in stem cell field)	19.8
Acceptance Rate(Highly selective; desk rejection rate exceeds 50%)	~10%
Time to First Decision(Relatively fast initial decisions; revision timeline varies widely)	30-45 days
Article Influence Score(Strong citation influence within stem cell research community)	6.8
5-Year Impact Factor(Papers continue accumulating citations over extended periods)	21.4
Submissions per Year(Lower volume than broader journals allows more thorough editorial assessment)	~1,200

Before you submit

Cell Stem Cell accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to Cell Stem Cell. ~30 minutes.

Run Free Readiness Scan See a sample report

Article Types

Research Article

No strict limit; typically 5,000-8,000 words with 6-8 main figures

Full-length original research reports representing major advances in stem cell biology. These form the core of the journal's content and require substantial mechanistic insight, rigorous lineage tracing or functional validation, and clear significance for the field.

Resource

Similar to Research Articles; emphasis on validation data

Papers that provide new tools, datasets, or protocols enabling significant new research directions. Must include proof-of-principle experiments demonstrating the resource's value for answering biological questions that weren't previously addressable.

Short Article

3,000-4,000 words with up to 4 main figures

Concise reports of exceptional findings that don't require the full development of a standard Research Article. These aren't lesser papers - they're complete stories that happen to be tellable in a more compact format.

Review

5,000-7,000 words; contact editors before writing

Typically commissioned from leading researchers, though exceptional unsolicited reviews are considered. Should offer genuine synthesis and new perspectives rather than summarizing recent literature.

Perspective

2,000-3,000 words

Opinion pieces on controversial topics, emerging concepts, or future directions in stem cell research. Should be thought-provoking and well-argued rather than merely descriptive. Usually commissioned but proposals welcome.

Landmark Cell Stem Cell Papers

Papers that defined fields and changed science:

Takahashi et al., 2006 - Demonstrated that mouse fibroblasts could be reprogrammed to pluripotent stem cells using four transcription factors
Festuccia et al., 2012 - Showed that Esrrb is a direct Nanog target gene that can sustain pluripotency without exogenous factors
Lamba et al., 2009 - Demonstrated transplantation of human embryonic stem cell-derived pancreatic endoderm generates insulin-producing cells
Clevers et al., 2014 - Published foundational work on Wnt signaling in stem cell self-renewal and tissue homeostasis
Yamanaka et al., 2007 - Extended induced pluripotency to human fibroblasts, opening paths to patient-specific disease modeling
Blanpain et al., 2011 - Defined the cancer stem cell concept in skin tumors through lineage tracing approaches

Preparing a Cell Stem Cell Submission?

Get pre-submission feedback from reviewers who've published in Cell Stem Cell and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected

Confidential

Primary Fields

Embryonic and adult stem cell self-renewal mechanismsPluripotency and reprogramming biologyLineage commitment and differentiation pathwaysStem cell niche interactions and microenvironmentTissue regeneration and repairCancer stem cells and tumor initiationiPSC disease modeling and drug discoveryOrganoid biology and applicationsAging effects on stem cell functionRegenerative medicine and cell therapy

Related Journal Guides

All journal guides

All articles

Ready to submit to Cell Stem Cell?

A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what Cell Stem Cell editors look for.

Need field-expert depth? Human review from $1,000